We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Product News   Nov 18, 2020

 
BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Credit: CDC/ Unsplash

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Optibrium Enhances Compound Design Strategies

Product News

Optibrium™ today announced the release of the newest version of StarDrop™, a comprehensive software platform for small molecule design, optimisation and data analysis.

READ MORE

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Product News

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression.

READ MORE

Thermo Extends SARS-CoV-2 Program to Support Research on New Virus Strains

Product News

Company makes subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE